Clinical Trials Supply & Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Service (Logistics & Distribution; Storage & Retention; Packaging, Labeling, & Blinding; Manufacturing; Comparator Sourcing; Others), By Phase (Phase 0, Phase I, Phase II, Phase III), By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Others), By End User Industry (Pharmaceutical v/s Medical Devices), By Company and By Region

June 2023 | 114 pages | ID: CC044C5C678CEN
TechSci Research

Abstracts

The global clinical trials supply & logistics market is projected to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases and cancers, an upsurge in demand for personalized medicines, and extensive development in technology, which are fueling the market's growth. A clinical trial is a process in which several experiments, tests, or studies are performed on animals and humans to analyze the results. Clinical trials are split into two types that are observational studies and interventional trials. The other factors supporting the market's growth are the rise in research and development activities, increasing research and development expenditure, a large number of clinical trials and research studies, huge demand for vaccinations, the growing aging population, and growing inorganic growth strategies such as mergers, acquisitions, collaborations, and others by pharmaceutical and biologics industries.

Rising Emphasis on Drug Development

The growing frequency of various types of diseases such as obesity, cardiovascular, diabetes, infectious, and cancer is surging the demand for drug development, which is bolstering the growth of the market globally. For instance, according to WHO, around 422 million people around the world have diabetes. Owing to the surge in the number of people suffering from different types of diseases, the rise in demand for the development of new therapies, drugs, and medical devices is augmenting the growth of the market. According to the WHO, more than 80 vaccines are presently being analyzed in clinical trials, with over 180 in the pre-clinical stage. Moreover, rising funding for drug development by government and non-government organizations is a contributing factor to the growth of the market. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), PhRMA affiliates have invested considerably in drug development efforts.

Technological Advancements

Technological advancement and innovations in healthcare and medicine are driving the growth of the market. For instance, in South Korea, Asan Medical Center (AMC) has developed a new system capable of handling clinical trial image data from group to extraction. The increasing adoption of new innovative technologies, such as cloud-enabled digital core, machine learning algorithms, radio-frequency identification (RFID), blockchain-based product tracking, and use of the internet of things to improve the quality management of clinical trial supply and logistics operations, are impelling the growth of the market. Heavy investments by several companies in advanced technologies and logistics are propelling the growth of the market. For instance, in 2020, Almac Clinical Technologies, a section of the Almac Group, proposed Simplify, a next-generation IRT solution. It is enabled with a standard array of configurable functionality intended to speed up the study startup process.

Growing Demand for Precision Medicines

The growing prominence of personalized medicines is one of the key factors supporting the growth of the market. For instance, in 2020, according to the scope and significance of the progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year. The rising demand for precision drugs is due to their efficiency in treating unique and complex diseases. New drugs and disease therapies are being developed due to the rising need and use by doctors, researchers, and pharmaceutical firms, which facilitates the growth of the market.

Market Segmentation

The global clinical trials supply & logistics market is segmented into service, phase, therapeutic area, end-user industry, and company. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labeling, & blinding, manufacturing, comparator sourcing, and others. Based on phase, the market is segmented into Phase 0, phase I, phase II, and Phase III. Based on therapeutic areas, the market is divided into oncology, cardiovascular diseases, neurological disorders, and others. Based on the end-user industry, the market is divided into pharmaceutical and medical devices. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising occurrences of various types of cancer and extensive technology development in the country.

Market Players

Thermo Fisher Scientific (Patheon), Catalent, Inc., United Parcel Service (Marken), PARAXEL International Corporation, Almac Group, Piramal Pharma Solutions (Piramal Group), UDG Healthcare, plc, DHL International Limited, Packaging Coordinators Inc., and Walden Group SAS (Movianto) are some of the leading companies operating in the market.

Report Scope:

In this report, global clinical trials supply & logistics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

• Clinical Trials Supply & Logistics Market, By Service:
• Logistics & Distribution
• Storage & Retention
• Packaging
• Labeling & Blinding
• Manufacturing
• Comparator Sourcing
• Others
• Clinical Trials Supply & Logistics Market, By Phase:
• Phase 0
• Phase I
• Phase II
• Phase III
• Clinical Trials Supply & Logistics Market, By Therapeutic Area:
• Oncology
• Cardiovascular Diseases
• Neurological Disorders
• Others
• Clinical Trials Supply & Logistics Market, By End User Industry:
• Pharmaceutical
• Medical Devices
• Clinical Trials Supply & Logistics Market, By Region:
• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• Europe & CIS
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Turkey
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Trials Supply & Logistics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. IMPACT OF COVID-19 ON GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET

5. VOICE OF CUSTOMER

6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Service (Logistics & Distribution; Storage & Retention; Packaging, Labeling, & Blinding; Manufacturing; Comparator Sourcing; Others)
  6.2.2. By Phase (Phase 0, Phase I, Phase II, Phase III)
  6.2.3. By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Others)
  6.2.4. By End User Industry (Pharmaceutical v/s Medical Devices)
  6.2.5. By Company (2021)
  6.2.6. By Region
6.3. Market Map

7. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Service
  7.2.2. By Phase
  7.2.3. By Therapeutic Area
  7.2.4. By End User Industry
  7.2.5. By Country
7.3. North America: Country Analysis
  7.3.1. United States Clinical Trial Supply & Logistics Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Service
      7.3.1.2.2. By Phase
      7.3.1.2.3. By Therapeutic Area
      7.3.1.2.4. By End User Industry
  7.3.2. Canada Clinical Trial Supply & Logistics Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Service
      7.3.2.2.2. By Phase
      7.3.2.2.3. By Therapeutic Area
      7.3.2.2.4. By End User Industry
  7.3.3. Mexico Clinical Trial Supply & Logistics Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Service
      7.3.3.2.2. By Phase
      7.3.3.2.3. By Therapeutic Area
      7.3.3.2.4. By End User Industry

8. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Service
  8.2.2. By Phase
  8.2.3. By Therapeutic Area
  8.2.4. By End User Industry
  8.2.5. By Country
8.3. Europe: Country Analysis
  8.3.1. France Clinical Trial Supply & Logistics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Service
      8.3.1.2.2. By Phase
      8.3.1.2.3. By Therapeutic Area
      8.3.1.2.4. By End User Industry
  8.3.2. Germany Clinical Trial Supply & Logistics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Service
      8.3.2.2.2. By Phase
      8.3.2.2.3. By Therapeutic Area
      8.3.2.2.4. By End User Industry
  8.3.3. United Kingdom Clinical Trial Supply & Logistics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Service
      8.3.3.2.2. By Phase
      8.3.3.2.3. By Therapeutic Area
      8.3.3.2.4. By End User Industry
  8.3.4. Italy Clinical Trial Supply & Logistics Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Service
      8.3.4.2.2. By Phase
      8.3.4.2.3. By Therapeutic Area
      8.3.4.2.4. By End User Industry
  8.3.5. Spain Clinical Trial Supply & Logistics Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Service
      8.3.5.2.2. By Phase
      8.3.5.2.3. By Therapeutic Area
      8.3.5.2.4. By End User Industry

9. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Service
  9.2.2. By Phase
  9.2.3. By Therapeutic Area
  9.2.4. By End User Industry
  9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Clinical Trial Supply & Logistics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Service
      9.3.1.2.2. By Phase
      9.3.1.2.3. By Therapeutic Area
      9.3.1.2.4. By End User Industry
  9.3.2. India Clinical Trial Supply & Logistics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Service
      9.3.2.2.2. By Phase
      9.3.2.2.3. By Therapeutic Area
      9.3.2.2.4. By End User Industry
  9.3.3. Japan Clinical Trial Supply & Logistics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Service
      9.3.3.2.2. By Phase
      9.3.3.2.3. By Therapeutic Area
      9.3.3.2.4. By End User Industry
  9.3.4. South Korea Clinical Trial Supply & Logistics Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Service
      9.3.4.2.2. By Phase
      9.3.4.2.3. By Therapeutic Area
      9.3.4.2.4. By End User Industry
  9.3.5. Australia Clinical Trial Supply & Logistics Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Service
      9.3.5.2.2. By Phase
      9.3.5.2.3. By Therapeutic Area
      9.3.5.2.4. By End User Industry

10. SOUTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Service
  10.2.2. By Phase
  10.2.3. By Therapeutic Area
  10.2.4. By End User Industry
  10.2.5. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Clinical Trial Supply & Logistics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Service
      10.3.1.2.2. By Phase
      10.3.1.2.3. By Therapeutic Area
      10.3.1.2.4. By End User Industry
  10.3.2. Argentina Clinical Trial Supply & Logistics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Service
      10.3.2.2.2. By Phase
      10.3.2.2.3. By Therapeutic Area
      10.3.2.2.4. By End User Industry
  10.3.3. Colombia Clinical Trial Supply & Logistics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Service
      10.3.3.2.2. By Phase
      10.3.3.2.3. By Therapeutic Area
      10.3.3.2.4. By End User Industry

11. MIDDLE EAST AND AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Service
  11.2.2. By Phase
  11.2.3. By Therapeutic Area
  11.2.4. By End User Industry
  11.2.5. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Clinical Trial Supply & Logistics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Service
      11.3.1.2.2. By Phase
      11.3.1.2.3. By Therapeutic Area
      11.3.1.2.4. By End User Industry
  11.3.2. Saudi Arabia Clinical Trial Supply & Logistics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Service
      11.3.2.2.2. By Phase
      11.3.2.2.3. By Therapeutic Area
      11.3.2.2.4. By End User Industry
  11.3.3. UAE Clinical Trial Supply & Logistics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Service
      11.3.3.2.2. By Phase
      11.3.3.2.3. By Therapeutic Area
      11.3.3.2.4. By End User Industry
  11.3.4. Turkey Clinical Trial Supply & Logistics Market Outlook
    11.3.4.1. Market Size & Forecast
      11.3.4.1.1. By Value
    11.3.4.2. Market Share & Forecast
      11.3.4.2.1. By Service
      11.3.4.2.2. By Phase
      11.3.4.2.3. By Therapeutic Area
      11.3.4.2.4. By End User Industry
  11.3.5. Egypt Clinical Trial Supply & Logistics Market Outlook
    11.3.5.1. Market Size & Forecast
      11.3.5.1.1. By Value
    11.3.5.2. Market Share & Forecast
      11.3.5.2.1. By Service
      11.3.5.2.2. By Phase
      11.3.5.2.3. By Therapeutic Area
      11.3.5.2.4. By End User Industry

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Thermo Fisher Scientific (Patheon)
14.2. Catalent, Inc.
14.3. United Parcel Service (Marken)
14.4. PARAXEL International Corporation
14.5. Almac Group
14.6. Piramal Pharma Solutions (Piramal Group)
14.7. UDG Healthcare, plc
14.8. DHL International Limited
14.9. Packaging Coordinators Inc.
14.10. Walden Group SAS (Movianto)

15. STRATEGIC RECOMMENDATIONS